169 related articles for article (PubMed ID: 22210920)
1. A case of estrogen receptor positive secretory carcinoma in a 9-Year-old girl with ETV6-NTRK3 fusion gene.
Yorozuya K; Takahashi E; Kousaka J; Mouri Y; Yoshida M; Fujii K; Akizuki M; Nakano S; Fukutomi T; Umemoto Y; Yokoi T; Imai H
Jpn J Clin Oncol; 2012 Mar; 42(3):208-11. PubMed ID: 22210920
[TBL] [Abstract][Full Text] [Related]
2. A case of quadruple primary malignancies including breast, tongue, and thyroid cancers and osteosarcoma in a young female without karyotype abnormality.
Kousaka J; Fujii K; Yorozuya K; Mouri Y; Yoshida M; Nakano S; Fukutomi T; Takahashi E; Yokoi T
Breast Cancer; 2014 Jul; 21(4):500-3. PubMed ID: 21562838
[TBL] [Abstract][Full Text] [Related]
3. ETV6-NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual.
Grabellus F; Worm K; Willruth A; Schmitz KJ; Otterbach F; Baba HA; Kimmig R; Metz KA
Breast; 2005 Feb; 14(1):71-4. PubMed ID: 15695086
[TBL] [Abstract][Full Text] [Related]
4. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression.
Vasudev P; Onuma K
Arch Pathol Lab Med; 2011 Dec; 135(12):1606-10. PubMed ID: 22129193
[TBL] [Abstract][Full Text] [Related]
5. Secretory Breast Carcinoma: A Histopathologic and Genomic Spectrum Characterized by a Joint Specific ETV6-NTRK3 Gene Fusion.
Del Castillo M; Chibon F; Arnould L; Croce S; Ribeiro A; Perot G; Hostein I; Geha S; Bozon C; Garnier A; Lae M; Vincent-Salomon A; MacGrogan G
Am J Surg Pathol; 2015 Nov; 39(11):1458-67. PubMed ID: 26291510
[TBL] [Abstract][Full Text] [Related]
6. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
[TBL] [Abstract][Full Text] [Related]
7. Mammary analog secretory carcinoma of salivary glands: a report of 2 cases with expression of basal/myoepithelial markers (calponin, CD10 and p63 protein).
Laco J; Švajdler M; Andrejs J; Hrubala D; Hácová M; Vaněček T; Skálová A; Ryška A
Pathol Res Pract; 2013 Mar; 209(3):167-72. PubMed ID: 23357688
[TBL] [Abstract][Full Text] [Related]
8. Primary Cutaneous Mammary Analog Secretory Carcinoma With ETV6-NTRK3 Translocation.
Amin SM; Beattie A; Ling X; Jennings LJ; Guitart J
Am J Dermatopathol; 2016 Nov; 38(11):842-845. PubMed ID: 27763904
[TBL] [Abstract][Full Text] [Related]
9. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
[TBL] [Abstract][Full Text] [Related]
10. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes.
Skálová A; Vanecek T; Majewska H; Laco J; Grossmann P; Simpson RH; Hauer L; Andrle P; Hosticka L; Branžovský J; Michal M
Am J Surg Pathol; 2014 Jan; 38(1):23-33. PubMed ID: 24145651
[TBL] [Abstract][Full Text] [Related]
11. A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off.
Reynolds S; Shaheen M; Olson G; Barry M; Wu J; Bocklage T
Head Neck Pathol; 2016 Sep; 10(3):405-13. PubMed ID: 27075025
[TBL] [Abstract][Full Text] [Related]
12. Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.
Skálová A; Vanecek T; Simpson RH; Laco J; Majewska H; Baneckova M; Steiner P; Michal M
Am J Surg Pathol; 2016 Jan; 40(1):3-13. PubMed ID: 26492182
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
[TBL] [Abstract][Full Text] [Related]
15. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
[TBL] [Abstract][Full Text] [Related]
16. Secretory carcinoma of the breast with a cystically dilated intraductal component: report of a case.
Izumi J; Komaki K; Hirokawa M; Masuda E; Monden Y
Surg Today; 2003; 33(2):110-3. PubMed ID: 12616371
[TBL] [Abstract][Full Text] [Related]
17. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
[TBL] [Abstract][Full Text] [Related]
18. Secretory carcinoma of the breast: a genetically defined carcinoma entity.
Diallo R; Tognon C; Knezevich SR; Sorensen P; Poremba C
Verh Dtsch Ges Pathol; 2003; 87():193-203. PubMed ID: 16888913
[TBL] [Abstract][Full Text] [Related]
19. Cytopathological features of mammary analogue secretory carcinoma--review of literature.
Takeda M; Kasai T; Morita K; Takeuchi M; Nishikawa T; Yamashita A; Mikami S; Hosoi H; Ohbayashi C
Diagn Cytopathol; 2015 Feb; 43(2):131-7. PubMed ID: 24652816
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
